74

This article provides a summary of the “Quoi de neuf en néphrologie?” (“What’s new in nephrology?”) session held at the 2023 SFNDT Congress in Liège, along with sessions looking at new developments in IgA nephropathy (IgAN) and ANCA-associated vasculitis. The agenda for the “Quoi de neuf en néphrologie?” session this year was to review key publications from non-nephrology journals, discussing topics such as nephroprotection, treatment of glomerulopathy (IgA and APOL1), clinical trials on hypertension, urolithiasis, and other areas of renal physiology, including estimation of glomerular filtration rate.